Mason W. Freeman
Chief Tech/Sci/R&D Officer presso CINCOR PHARMA, INC.
Profilo
Mason W.
Freeman is currently the Director of Translational Medicine at The General Hospital Corp.
He is also a Venture Partner at 5AM Venture Management LLC and a Professor at Harvard Medical School.
Additionally, he holds the position of Chief Medical Officer at CinCor Pharma, Inc. starting in 2022.
In his former roles, Dr. Freeman served as a Director at Envoy Therapeutics, Inc. and Mitobridge, Inc. He was also a Director at scPharmaceuticals, Inc. from 2018 to 2020 and an Independent Director at Crinetics Pharmaceuticals, Inc. from 2015 to 2019.
Prior to that, he was the Head of Translational Medicine at Novartis AG from 2005 to 2007.
Dr. Freeman completed his undergraduate studies at Harvard University and obtained a doctorate degree from the University of California.
Posizioni attive di Mason W. Freeman
| Società | Posizione | Inizio |
|---|---|---|
| CINCOR PHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/03/2022 |
| Harvard Medical School | Corporate Officer/Principal | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Private Equity Investor | 01/01/2008 |
Precedenti posizioni note di Mason W. Freeman
| Società | Posizione | Fine |
|---|---|---|
| SCPHARMACEUTICALS INC. | Director/Board Member | 01/12/2020 |
| CRINETICS PHARMACEUTICALS, INC. | Director/Board Member | 01/07/2019 |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Director/Board Member | 01/01/2018 |
| NOVARTIS AG | Corporate Officer/Principal | 01/04/2007 |
Envoy Therapeutics, Inc.
 Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Envoy Therapeutics, Inc. manufactures and develops therapeutic drugs for neurological and psychiatric diseases. It was founded in 2009 and is headquartered in Jupiter, FL. | Director/Board Member | - |
Formazione di Mason W. Freeman
| Harvard University | Undergraduate Degree |
| University of California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| SCPHARMACEUTICALS INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
Envoy Therapeutics, Inc.
Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Envoy Therapeutics, Inc. manufactures and develops therapeutic drugs for neurological and psychiatric diseases. It was founded in 2009 and is headquartered in Jupiter, FL. | Health Technology |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Mason W. Freeman
